Compare MAP Boga Adiperkasa Tbk. (MAPB) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MAP Boga Adiperkasa Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? MAP Boga Adiperkasa Tbk. trades at Rp1,260 (market cap 3.01T), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: MAP Boga Adiperkasa Tbk. is far larger — about 28.8× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| MAPB | SCPI | |
|---|---|---|
Market Cap | 3.01T | 104.4B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MAP Boga Adiperkasa Tbk.
PT. Map Boga Adiperkasa (formerly PT. Creasi Aksesoris Indonesia) (the Company) was established based on notarial deed No. 01 dated January 7, 2013 of Lilis Sugianto, S.H., notary in Jakarta.
Read more on MAPB →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
